DISAMPING KANAN INI.............
PLEASE USE ........ "TRANSLATE MACHINE" .. GOOGLE TRANSLATE BESIDE RIGHT THIS
........................
The parasite that escaped out
of Africa: Tracing origins of malaria parasite
Date:
February 21,
2014
Source:
Perelman School of Medicine at the
University of Pennsylvania
Summary:
An international team has traced the origin of the
second-worst malaria parasite of humans to Africa. The closest genetic
relatives of human Plasmodium vivax were found only in Asian macaques, leading
researchers to believe that P. vivax originated in Asia. This study overturns
that, finding that wild-living apes in central Africa are widely infected with
parasites that, genetically, are nearly identical to human P. Vivax
..............................
An
international team of scientists has traced the origin of Plasmodium vivax, the
second-worst malaria parasite of humans, to Africa, according to a study
published this week in Nature
Communications. Until recently, the closest genetic relatives of
human P. vivax
were found only in Asian macaques, leading researchers to believe that P. vivax
originated in Asia.
The study,
led by researchers from the Perelman School of Medicine at the University of
Pennsylvania, found that wild-living apes in central Africa are widely infected
with parasites that, genetically, are nearly identical to human P. vivax.
This finding
overturns the dogma that P. vivax originated in Asia, despite being most
prevalent in humans there now, and also solves other vexing questions about P.
vivax infection: how a mutation conferring resistance to P. vivax occurs at
high frequency in the very region where this parasite seems absent and how
travelers returning from regions where almost all humans lack the receptor for
P. vivax can be infected with this parasite.
Of Ape and
Human Parasites
Members of
the labs of Beatrice Hahn, MD, and George Shaw, MD, PhD, both professors of
Medicine and Microbiology at Penn, in collaboration with Paul Sharp, PhD, an
evolutionary biologist from the University of Edinburgh, and Martine Peeters,
PhD, a microbiologist from the Institut de Recherche pour le Développement and
the University of Montpellier, tested over 5,000 ape fecal samples from dozens
of field stations and sanctuaries in Africa for P. vivax DNA. They found P.
vivax-like sequences in chimpanzees, in western and eastern gorillas, but not
in bonobos. Ape P. vivax was highly prevalent in wild communities, exhibiting
infection rates consistent with stable transmission of the parasite within the
wild apes.
Ape P. vivax
infects both gorillas and chimpanzees, unlike the ape precursor of P.
falciparum, the deadliest human malaria parasite, which only infects gorillas.
The origin of P. falciparum in gorillas was discovered several years ago by the
same international group of investigators. The team continued its widespread
screen of malaria parasite DNA in wild-living primates, and noted that P. vivax
was also endemic in gorillas and chimpanzees in central Africa.
To examine
the evolutionary relationships between ape and human parasites, the team
generated parasite DNA sequences from wild and sanctuary apes, as well as from
a global sampling of human P. vivax infections. They constructed a family tree
of the sequences and found that ape and human parasites were very closely
related. But ape parasites were more diverse than the human parasites and did
not group according to their host species. In contrast, the human parasites
formed a single lineage that fell within the branches of ape parasite
sequences.
From these
evolutionary relationships, the team concluded that P. vivax is of African --
not Asian -- origin, and that all existing human P. vivax parasites evolved
from a single ancestor that spread out of Africa. The high prevalence of P.
vivax in wild-living apes, along with the recent finding of ape P. vivax in a
European traveler, indicates the existence of a substantial natural reservoir
of P. vivax in Africa.
Solving a
Paradox
Of the five
Plasmodium species known to cause malaria in humans, P. vivax is the most
widespread. Although highly prevalent in Asia and Latin America, P. vivax was
thought to be absent from west and central Africa due to a mutation that causes
the Duffy-negative phenotype in most indigenous African people.
P. vivax
parasites enter human red blood cells via the Duffy protein receptor. Because
the absence of the receptor on the surface of these cells confers protection
against P. vivax malaria, this parasite has long been suspected to be the agent
that selected for this mutation. However, this hypothesis had been difficult to
reconcile with the belief that P. vivax originated in Asia.
"Our
finding that wild-living apes in central Africa show widespread infection with
diverse strains of P. vivax provides new insight into the evolutionary history
of human P. vivax and resolves the paradox that a mutation conferring
resistance to P. vivax occurs with high frequency in the very region where this
parasite is absent in humans," says Hahn.
"One
interpretation of the relationships that we observed is that a single host
switch from apes gave rise to human P. vivax, analogous to the origin of human
P. falciparum," Sharp adds. "However, this seems unlikely in this
case since ape P. vivax does not divide into gorilla- and chimpanzee-specific
lineages. "
A more
plausible scenario, say the researchers, is that an ancestral P. vivax stock
was able to infect humans, gorillas, and chimpanzees in Africa until the Duffy
negative mutation started to spread -- around 30,000 years ago -- and
eliminated P. vivax from humans there. Under this scenario, existing
human-infecting P. vivax is a parasite that survived after spreading out of Africa.
Forest
Reservoirs
"The
existence of a P. vivax reservoir within the forests of central Africa has
public health implications," notes Peeters. "First, it solves the
mystery of P. vivax infections in travelers returning from regions where 99
percent of the human population is Duffy negative. It also raises the
possibility that Duffy positive humans whose work may bring them in close
proximity to chimpanzees and gorillas may become infected by ape P. vivax. This
has already happened once and may happen again, with unknown
consequences."
The team is
also concerned about the possibility that ape P. vivax may spread via
international travel to countries where human P. vivax is actively transmitted.
Since ape P. vivax is more diverse, genetically, than human P. vivax, it
potentially has more versatility to escape treatment and prevention measures,
especially if human and ape parasites were able to recombine.
Given what
biologists know about P. vivax's ability to switch hosts, the team suggests it
is important to screen Duffy positive and negative humans in west central
Africa, as well as transmitting mosquito vectors, for the presence of ape P.
vivax. Such studies are now possible through the development of molecular tools
that distinguish ape from human P. vivax. This information is necessary to
inform malaria control and eradication efforts of the propensity of ape P.
vivax to cross over to humans.
As a next
step, the team will compare and contrast the molecular and biological
properties of human and ape parasites to identify host-specific interactions
and transmission requirements, thereby uncovering vulnerabilities that can be
exploited to combat human malaria.
Story
Source:
The above
story is based on materials provided by Perelman
School of Medicine at the University of Pennsylvania. Note:
Materials may be edited for content and length.
Journal
Reference:
Weimin Liu, Yingying Li,
Katharina S. Shaw, Gerald H. Learn, Lindsey J. Plenderleith, Jordan A.
Malenke, Sesh A. Sundararaman, Miguel A. Ramirez, Patricia A. Crystal,
Andrew G. Smith, Frederic Bibollet-Ruche, Ahidjo Ayouba, Sabrina
Locatelli, Amandine Esteban, Fatima Mouacha, Emilande Guichet, Christelle
Butel, Steve Ahuka-Mundeke, Bila-Isia Inogwabini, Jean-Bosco N. Ndjango,
Sheri Speede, Crickette M. Sanz, David B. Morgan, Mary K. Gonder, Philip
J. Kranzusch, Peter D. Walsh, Alexander V. Georgiev, Martin N. Muller,
Alex K. Piel, Fiona A. Stewart, Michael L. Wilson, Anne E. Pusey, Liwang
Cui, Zenglei Wang, Anna Färnert, Colin J. Sutherland, Debbie Nolder, John
A. Hart, Terese B. Hart, Paco Bertolani, Amethyst Gillis, Matthew
LeBreton, Babila Tafon, John Kiyang, Cyrille F. Djoko, Bradley S.
Schneider, Nathan D. Wolfe, Eitel Mpoudi-Ngole, Eric Delaporte, Richard
Carter, Richard L. Culleton, George M. Shaw, Julian C. Rayner, Martine
Peeters, Beatrice H. Hahn, Paul M. Sharp. African origin of the malaria
parasite Plasmodium vivax. Nature Communications, 2014; 5 DOI: 10.1038/ncomms4346